TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -1 | -1 | 5 | -3 | 6 | -21 | -2 |
| S | %wins | 50 | 50 | 50 | 50 | 0 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/17/20 16:48 | 12/16/20 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Monnet Dominique | NV | O | P,CEO | S | -1,300 | 2.60 | 0 | -500 | -40 | 735 | D | ||||||||||||||
5/22/15 17:30 | 5/20/15 | ALXN | Alexion Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Monnet Dominique | CT | O | SVP,CMO | S | -42 | 162.40 | 33 | 0 | -3 | 9 | D | 64 | 8 | -12 | -9 | -8 | -2 | 5 | 3 | -4 | -5 | 10 | 4 | 3 | -17 |
2/12/15 21:07 | 2/10/15 | ALXN | Alexion Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Monnet Dominique | CT | O | SVP,CMO | S | -56 | 171.15 | 33 | 0 | -6 | 5 | D | 88 | -1 | 8 | -11 | -6 | -4 | -3 | -1 | 3 | 3 | 0 | -10 | 9 | -24 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |